CYP2A6
Reactivité: Humain
WB, ELISA
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
Western Blot (1-2 μg/mL) The optimal working dilution should be determined by the end user.
Restrictions
For Research Use only
Format
Liquid
Buffer
In PBS (0.08 % sodium azide)
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
-20 °C
Stockage commentaire
Store at -20°C. Aliquot to avoid repeated freezing and thawing.
Higashi, Nakajima, Katoh, Tokudome, Yokoi: "Inhibitory effects of neurotransmitters and steroids on human CYP2A6." dans: Drug metabolism and disposition: the biological fate of chemicals, Vol. 35, Issue 4, pp. 508-14, (2007) (PubMed).
Audrain-McGovern, Al Koudsi, Rodriguez, Wileyto, Shields, Tyndale: "The role of CYP2A6 in the emergence of nicotine dependence in adolescents." dans: Pediatrics, Vol. 119, Issue 1, pp. e264-74, (2007) (PubMed).
Swan, Benowitz, Lessov, Jacob, Tyndale, Wilhelmsen: "Nicotine metabolism: the impact of CYP2A6 on estimates of additive genetic influence." dans: Pharmacogenetics and genomics, Vol. 15, Issue 2, pp. 115-25, (2005) (PubMed).
Antigène
CYP2A6
(Cytochrome P450, Family 2, Subfamily A, Polypeptide 6 (CYP2A6))